Rating Change
UBS analysts reiterated a Neutral rating on RXO, Inc. (NYSE:RXO) on June 30, 2026.
reiterateNYSE:RXO
UBS Reiterates Neutral Rating on RXO, Inc. (RXO)
Rating Change UBS analysts reiterated a Neutral rating on RXO, Inc. (NYSE:RXO) on June 30, 2026. Market Context RXO, Inc.
Market Context
RXO, Inc. operates in the Industrials sector. The stock currently trades at $27.59 with a market capitalization of $2.5B.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for RXO, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for RXO, Inc.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 30, 2026 | UBS | Neutral | N/A |
| Jun 26, 2026 | Barclays | Overweight | N/A |
| May 15, 2026 | Stifel | Buy | N/A |
| May 08, 2026 | UBS | Neutral | N/A |
| May 08, 2026 | Barclays | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View RXO Stock Page
Frequently Asked Questions
What does a Neutral rating mean for RXO?
A Neutral rating from UBS reflects the analyst's outlook on RXO, Inc. (NYSE:RXO). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RXO forecast page.